Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Geranyl acetate can protect skin cells from damage and inflammation caused by para-phenylenediamine.

4-aminopyridine helps heal burn wounds faster by reducing inflammation and promoting new blood vessel growth.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

4-aminopyridine speeds up and improves skin wound healing.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Nilotinib can cause keratosis pilaris, a skin condition.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Pantethine may boost the immune system's ability to fight sarcoma.

Platelet-rich plasma helps protect and improve ovarian function in rats treated with cyclophosphamide.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

α-parvin is necessary for skin and hair growth and for the correct orientation of skin cells.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Paroxetine relieves pain by increasing allopregnanolone levels.

ALRN-6924 may prevent hair loss caused by chemotherapy.